Industry Analysis
ASML's "letter T" designation is classic pre-order expectation management, but the real signal is the 2029-2030 delivery window. That timeline embeds EUV procurement into a five-year advanced-node fab buildout cycle.
Technical cascade: EUV is not a single tool purchase. It anchors Zeiss optics, photoresist supply, KLA metrology, and cleanroom infrastructure simultaneously. If Terafab targets 2029 production, it must already be running DUV yield ramp and High-NA process validation—effectively replicating a full advanced-node line.
Compliance exposure: As the sole EUV supplier, ASML's customer geography directly intersects BIS export-control frameworks. A US-based Terafab sidesteps China restrictions but intensifies Washington's anxiety over advanced-capacity concentration. The 2029-2030 window lands squarely in the next regulatory revision cycle, making policy uncertainty a hidden cost.
Competitive dynamics: The TSMC-Samsung-Intel triad faces its first credible fourth-pole threat. ASML's customer concentration (TSMC dominates EUV volume) has long capped its valuation multiple. Terafab's entry diversifies revenue while forcing rivals to accelerate Chiplet and HBM differentiation to dilute EUV dependency.
12-24 month tail: ASML's 2025-26 order book will reflect Terafab's DUV/High-NA reservations first; cleanroom capex peaks in H2 2026; and the EUV photoresist/mask supply chain sees its first major non-TSMC/Samsung volume surge.
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.